Biocon’s consolidated Q3FY22 revenue grows by 18 per cent YoY to Rs 2,223 crores EP News Bureau Jan 22, 2022 Biosimilars up by 28 per cent at Rs 981 crores; research services up by 10 per cent at Rs 641 crores and generics up by seven per…
Biocon Q1FY22 revenue at Rs 1,808 crores, up six per cent EP News Bureau Jul 23, 2021 Biosimilars up 10 per cent at Rs 758 crores and research services up 41 per cent at Rs 595 crores
